Vor Biopharma Price Target Maintained With a $12.00/Share by JMP Securities

Dow JonesDec 11 00:51 · Ratings

Oppenheimer Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $8

Futu NewsDec 10 05:31 · Ratings

Vor Biopharma Reports Promising Phase 1/2 Study Results

TipRanksDec 9 21:11

Stifel Nicolaus Remains a Buy on Vor Biopharma (VOR)

TipRanksDec 9 20:57 · Ratings

Vor Bio Presents Data on AML Therapy at ASH 2024 Annual Meeting

BenzingaDec 9 20:33

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback From FDA Regarding Registrational Trial Design

Vor BiopharmaDec 9 13:00